Longeveron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Longeveron and other ETFs, options, and stocks.About LGVN
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors.
CEOThan Powell
CEOThan Powell
Employees26
Employees26
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded2014
Founded2014
Employees26
Employees26
LGVN Key Statistics
Market cap11.44M
Market cap11.44M
Price-Earnings ratio-0.41
Price-Earnings ratio-0.41
Dividend yield—
Dividend yield—
Average volume273.02K
Average volume273.02K
High today$0.565
High today$0.565
Low today$0.5352
Low today$0.5352
Open price$0.541
Open price$0.541
Volume107.56K
Volume107.56K
52 Week high$1.92
52 Week high$1.92
52 Week low$0.492
52 Week low$0.492
Stock Snapshot
Longeveron(LGVN) stock is priced at $0.56, giving the company a market capitalization of 11.44M. It carries a P/E multiple of -0.41.
On 2026-01-14, Longeveron(LGVN) stock traded between a low of $0.54 and a high of $0.57. Shares are currently priced at $0.56, which is +4.2% above the low and -1.3% below the high.
Longeveron(LGVN) shares are trading with a volume of 107.56K, against a daily average of 273.02K.
During the past year, Longeveron(LGVN) stock moved between $0.49 at its lowest and $1.92 at its peak.
During the past year, Longeveron(LGVN) stock moved between $0.49 at its lowest and $1.92 at its peak.
People also own
Based on the portfolios of people who own LGVN. This list is generated using Robinhood data, and it’s not a recommendation.